Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in The American Journal of Pathology, published by Elsevier, scientists report the discovery of an increased level of the neuroprotein sortilin in pancreatic cancer cells that may open up the way to developing more effective treatment.
- ‘Best’ hospitals should be required to deliver tobacco treatment
- Suspension of fertility treatments during COVID-19 has mental health impacts
- 40% of O’ahu, Hawai’i beaches could be lost by mid-century
- E. coli bacteria offer path to improving photosynthesis
- Hyperbolic metamaterials exhibit 2T physics